DoW Tick-Borne Disease Therapeutic/Diagnostic Research Award
DOD-AMRAA Posted HT942526TBDRPTDRA
Close Date:
October 22, 2026
81 days remaining
Description
Summary: The intent of the fiscal year 2026 (FY26) Tick-Borne Disease Research Program (TBDRP) Therapeutic/Diagnostic Research Award (TDRA) is to support product-driven therapeutic and diagnostic development research aimed at reducing the burden of Lyme disease and/or other tick-borne diseases and conditions, and improving patient care and/or quality of life. Treatment-focused applications should be therapeutic evaluation studies designed to advance new ideas aimed at drug or treatment discovery that are still in the early/preclinical stages of development. Diagnosis-focused applications should propose diagnostic approaches that will be readily integrated into clinical settings. https://cdmrp.health.mil/pubs/press/2026/tbdrppreann
Actions
Funding Details
- Award Floor
- Not specified
- Award Ceiling
- Not specified
- Total Estimated Funding
- $2,650,000.00
- Expected Awards
- 2
Key Dates
- Posted
- May 5, 2026
- Closes
- October 22, 2026 81d
- Archive Date
- November 21, 2026
Agency Information
- Agency Name
- Defense Health Agency Contracting Activity - DHACA
- Agency Code
- DOD-AMRAA
- Funding Instrument
- Other